HLI
$139.51+0.56 (+0.40%)
Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructurings and liability management, and financial and valuation advisory services worldwide.
Recent News
Q4 Earnings Outperformers: Houlihan Lokey (NYSE:HLI) And The Rest Of The Investment Banking & Brokerage Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the investment banking & brokerage industry, including Houlihan Lokey (NYSE:HLI) and its peers.
2 Growth Stocks with All-Star Potential and 1 Facing Challenges
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
How The Evolving Investment Narrative Is Reframing Helia Group’s (ASX:HLI) Fair Value Story
Helia Group’s consensus analyst fair value has shifted slightly, with the target moving from A$4.35 to about A$4.27 per share. This trim lines up with broader research across financial services, where analysts are adjusting targets but not treating Helia as an outlier. As you read on, you will see how this evolving narrative might shape the way you track Helia’s story from here. Stay updated as the Fair Value for Helia Group shifts by adding it to your watchlist or portfolio. Alternatively,...
Affirm, Houlihan Lokey, Shift4, Fiserv, and Paymentus Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after investors raised concerns over the stability of the private credit market, following a key announcement from a major bank.
Medtech industry value to be driven by infrastructure over next decade
Analysis by Houlihan Lokey suggests that healthcare institutions are favouring medical equipment that readily fits in with their existing systems.